Inventor
SHEILA DEWITT
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes21%
C07BGeneral methods of organic chemistry17%
Y02ATechnologies for adaptation to climate change8%
PatentTitleYear
11,918,5695-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same202411,820,7203-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the same202311,773,080Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same202311,535,603Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same202211,491,1563-(substituted-4-oxoquinazolin-3(4202211,319,313Crystalline forms of deuterium-enriched pioglitazone202211,141,411Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to POXEL SA (3)· patent assignee history
2021–2024Based in US· patent location history
2022–2023Patents assigned to DEUTERX LLC (3)· patent assignee history
2023Patents assigned to SALARIUS PHARMACEUTICALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DEUTERX LLC | 3 | 2022–2023 |
| POXEL SA | 3 | 2021–2024 |
| SALARIUS PHARMACEUTICALS INC | 2 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2024 |